Distal Convoluted Tubule Transport
USMLE Step 1 trap: Confuses the target of loop diuretics (NKCC2/TAL) with the DCT NCC transporter. Loop diuretics (furosemide) inhibit NKCC2 in the TAL; thiazide diuretics inhibit NCC in the DCT.
The distal convoluted tubule (DCT) is a short but high-yield segment that shows up repeatedly on USMLE Step 1 — mostly because two major diuretic classes and two genetic syndromes hinge on understanding exactly what happens here. The key transporter is NCC (sodium-chloride cotransporter), which reabsorbs Na+ and Cl- together on the apical membrane. Thiazide diuretics block NCC directly. The DCT also handles calcium in a unique way: PTH and thiazides both increase Ca2+ reabsorption here, which is the opposite of what most students expect from a diuretic.
The exam tests this at multiple levels. Basic recall questions ask which transporter thiazides hit. Application questions ask you to predict electrolyte changes after thiazide use or identify a disease pattern from labs. Passage-based questions might describe a patient with hypokalemia, metabolic alkalosis, and low urine calcium — and you need to recognize Gitelman syndrome and distinguish it from Bartter syndrome. USMLE Step 1 loves using these two genetic syndromes as foils for each other and for their respective diuretics.
The tricky part is that students conflate the DCT with the loop of Henle. Both involve Na+ reabsorption, both are targets of diuretics, and both have associated genetic syndromes — but the transporters, ions, and calcium effects are completely different. Getting loop versus DCT physiology crossed is the most common mistake, and it cascades into wrong answers about diuretic effects, calcium handling, and genetic syndromes.
Common misconceptions
What the exam tests
- Know the NCC cotransporter: it reabsorbs sodium and chloride in the DCT, and thiazide diuretics (hydrochlorothiazide, chlorthalidone) are the class that specifically inhibits it — not loop diuretics.
- Understand how thiazides affect calcium: by blocking NCC, thiazides lower intracellular Na+, which enhances basolateral Na+/Ca2+ exchange, pulling more Ca2+ out of the cell and ultimately increasing DCT calcium reabsorption — resulting in hypocalciuria, not hypercalciuria.
- Recognize Gitelman syndrome by its pattern: loss-of-function mutation in NCC causes hypokalemia, metabolic alkalosis, hypomagnesemia, and hypocalciuria — it mimics thiazide use, not loop diuretic use, and is distinguished from Bartter syndrome by that low urine calcium.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →